Page last updated: 2024-10-21

5-hydroxydecanoate and Pancreatic Neoplasms

5-hydroxydecanoate has been researched along with Pancreatic Neoplasms in 1 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaggar, JH1
Squires, PE1
Dunne, MJ1

Other Studies

1 other study available for 5-hydroxydecanoate and Pancreatic Neoplasms

ArticleYear
Effects of 5-hydroxydecanoate on ATP-regulated potassium ion channels in insulin secreting cells.
    Biochemical Society transactions, 1993, Volume: 21, Issue:4

    Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Cytosol; Decanoic Acids; Hydroxy Acids; Insulin

1993